Company: ATHE
Filing Date: 2025-08-29
Form Type: 20-F
Source: 0001213900-25-082027
Chunk: 95

Company: ALTERITY THERAPEUTICS LTD
Filing Date: 2025-08-29
Form: 20-F
Item: Item 6
Chunk 95
---
 average                                        average                                        average
                                                                                    exercise                                       exercise                                       exercise
                                                                                       price                                          price                                          price
                                                                                        (A$)                                           (A$)                                           (A$)
Options outstanding at the beginning of the year            381,542,720                $0.05               170,042,720                $0.05               184,692,720                $0.05
Granted                                                               -               $0.004               217,000,000               $0.004                         -                   $-
Exercised                                                    (6,333,333   )               $-                         -                   $-                         -                   $-
Expired/forfeited                                            (4,650,000   )            $0.04                (2,500,000   )            $0.04               (13,150,000   )            $0.11
Lapsed                                                      (12,000,000   )            $0.04                (2,500,000   )            $0.04                (1,500,000   )            $0.02
Options outstanding at the end of the year                  358,559,387                $0.02               381,542,720                $0.02               170,042,720                $0.05
Options exercisable at the end of the year                  275,689,612                $0.03               195,708,100                $0.03                87,280,755                $0.06
Australian Disclosure Requirements

Indemnifying directors and officers

During the financial year, we maintained an insurance policy to indemnify all current Directors and Officers against certain liabilities incurred as a Director or Officer, including costs and expenses associated in successfully defending legal proceedings. The contract of insurance prohibits disclosure of the nature of the liability and the amount of the premium. We have not otherwise, during or since the financial year, indemnified or agreed to indemnify an Officer or Auditor of our Group or any related body corporate against a liability incurred as such an Officer or Auditor.

59

Share options on issue during or since the end of the financial year

During or since the end of the financial year the unissued ordinary shares of Alterity Therapeutics Limited under options were as follows:

  Date of expiry       Exercise           Number      
                        price             under       
                         (A$)            options      
------------------------------------------------------
September 17, 2025          0.09            35,000,